Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study - The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2825%2900405-2/fulltext

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service